| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.115 | 5.067 | 10.412 | 12.438 | 15.181 | 11.608 | 15.879 | 10.594 | 9.941 | 12.722 |
| Total Income - EUR | 5.115 | 5.067 | 10.412 | 12.438 | 15.181 | 11.608 | 15.879 | 10.594 | 9.941 | 12.722 |
| Total Expenses - EUR | 1.261 | 1.573 | 4.521 | 7.047 | 12.857 | 9.448 | 14.626 | 8.780 | 9.355 | 12.051 |
| Gross Profit/Loss - EUR | 3.854 | 3.494 | 5.890 | 5.391 | 2.324 | 2.160 | 1.253 | 1.814 | 586 | 671 |
| Net Profit/Loss - EUR | 3.701 | 3.342 | 5.578 | 5.015 | 1.869 | 1.812 | 777 | 1.497 | 492 | 563 |
| Employees | 2 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Avicenna Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.852 | 946 | 49.093 | 78.928 | 80.571 | 70.576 | 56.932 | 52.748 | 47.614 | 38.231 |
| Current Assets | 11.235 | 15.383 | 9.835 | 1.989 | 470 | 420 | 1.245 | 2.955 | 1.538 | 1.844 |
| Inventories | 0 | 919 | 0 | 212 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 204 | 202 | 361 | 194 | 191 | 167 | 477 | 334 | 95 | 410 |
| Cash | 11.032 | 14.262 | 9.473 | 1.582 | 279 | 253 | 768 | 2.621 | 1.443 | 1.434 |
| Shareholders Funds | 12.854 | 16.064 | 21.371 | 25.993 | 27.358 | 28.651 | 28.793 | 30.379 | 30.779 | 31.171 |
| Social Capital | 1.606 | 1.590 | 1.563 | 1.534 | 1.505 | 1.476 | 1.443 | 1.448 | 1.443 | 1.435 |
| Debts | 234 | 265 | 37.557 | 54.924 | 53.683 | 42.344 | 29.384 | 25.325 | 18.373 | 8.904 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Avicenna Med Srl